{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:41:46Z","timestamp":1786250506697,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA263488"],"award-info":[{"award-number":["K08CA263488"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The SOUND trial, published in 2023, demonstrated the oncologic safety of sentinel lymph node biopsy (SLNB) for select patients with early-stage breast cancer. We evaluated whether earlier awareness of the results of the SOUND trial was associated with increased intent to implement SLNB omission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter, cross-sectional study surveyed North American physicians on current SLNB use, awareness of the SOUND trial results, and intent to implement trial findings.\u00a0Intent was measured using the Innovation-Specific Implementation Intentions scale and scenario-based questions (ages 50 vs 60; whole- vs partial-breast irradiation), on a 5-point scale.\u00a0The primary outcome was high intent to omit SLNB (\u201cmoderate\u201d to \u201cvery great\u201d extent). Multiple logistic regression identified factors associated with intent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The response rate was 21% (208\/1004): 148 (71.5%) surgeons, 32 (13.04%) medical and 27 (15.46%) radiation oncologists. Overall, 47.8% had already omitted SLNB in select patients aged &lt;\u00a070 years, and 63.6% reported high intent to use SOUND results. Among those who had not yet omitted SLNB (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0108), 59.3% had high intent. Length of awareness of the SOUND trial (odds ratio 1.13) and practicing in Northeast USA vs Western USA (odds ratio 3.45,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.032) were associated with increased intent to omit SLNB. In scenario-based questions, most endorsed omission for a 60-year-old patient receiving whole-breast irradiation (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0105 [50.5%]); willingness decreased for a 50 year old or when partial-breast irradiation was planned. Across scenarios, intent was not associated with SOUND awareness duration, clinician characteristics, or referral workflows.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Earlier awareness of the SOUND trial and regional differences were associated with greater intent to omit SLNB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19792-x","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:59:09Z","timestamp":1778777949000},"page":"8165-8174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Clinical Trial Awareness to Practice: Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial"],"prefix":"10.1245","volume":"33","author":[{"given":"Ko Un","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Delisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaa S.","family":"Punglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Woodbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Mittendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"11","key":"19792_CR1","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol."},{"key":"19792_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer \u2014 primary results of the INSEMA trial. N Engl J Med. 2025;392:1051\u201364.","journal-title":"N Engl J Med."},{"key":"19792_CR3","unstructured":"Sentinel Lymph Node Biopsy May Be Safely Omitted in Some Patients With Early-stage Breast Cancer. American Association for Cancer Research (AACR). Available from: https:\/\/www.aacr.org\/about-the-aacr\/newsroom\/news-releases\/sentinel-lymph-node-biopsy-may-be-safely-omitted-in-some-patients-with-early-stage-breast-cancer\/. Accessed 16 Dec 2025."},{"key":"19792_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-00099","author":"KU Park","year":"2025","unstructured":"Park KU, Somerfield MR, Anne N, et al. Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO-25-00099.","journal-title":"J Clin Oncol."},{"key":"19792_CR5","unstructured":"SSO Choosing Wisely: Five things physicians and patients should question. Choosing Wisely. Available from: https:\/\/www.surgonc.org\/wp-content\/uploads\/2020\/11\/SSO-5things-List_2020-Updates-11-2020.pdf. Accessed 16 Apr 2024."},{"key":"19792_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamasurg.2020.6942","volume":"156","author":"T Wang","year":"2021","unstructured":"Wang T, Bredbeck BC, Sinco B, et al. Variations in persistent use of low-value breast cancer surgery. JAMA Surgery. 2021;156:353\u201362.","journal-title":"JAMA Surgery."},{"key":"19792_CR7","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1245\/s10434-022-11631-z","volume":"29","author":"BC Bredbeck","year":"2022","unstructured":"Bredbeck BC, Mott NM, Wang T, et al. Facility-level variation of low-value breast cancer treatments in older women with early-stage breast cancer: analysis of a statewide claims registry. Ann Surg Oncol. 2022;29:4155\u201364.","journal-title":"Ann Surg Oncol."},{"key":"19792_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.17129","volume":"3","author":"T Wang","year":"2020","unstructured":"Wang T, Mott N, Miller J, et al. Patient perspectives on treatment options for older women with hormone receptor-positive breast cancer: a qualitative study. JAMA Network Open. 2020;3:e2017129.","journal-title":"JAMA Network Open."},{"key":"19792_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","volume":"21","author":"O Gentilini","year":"2012","unstructured":"Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? a new trial in progress at the European institute of oncology of milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast. 2012;21:678\u201381. https:\/\/doi.org\/10.1016\/j.breast.2012.06.013.","journal-title":"Breast."},{"key":"19792_CR10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","volume":"42","author":"O Gentilini","year":"2016","unstructured":"Gentilini O, Botteri E, Dadda P, et al. Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial. Eur J Surg Oncol. 2016;42:685\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"19792_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13012-022-01225-4","volume":"17","author":"AA Baumann","year":"2022","unstructured":"Baumann AA, Hooley C, Kryzer E, et al. A scoping review of frameworks in empirical studies and a review of dissemination frameworks. Implement Sci. 2022;17:53.","journal-title":"Implement Sci."},{"key":"19792_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10488-010-0327-7","volume":"38","author":"GA Aarons","year":"2011","unstructured":"Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011;38:4\u201323. https:\/\/doi.org\/10.1007\/s10488-010-0327-7.","journal-title":"Adm Policy Ment Health."},{"key":"19792_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12961-015-0005-z","volume":"13","author":"JC Moullin","year":"2015","unstructured":"Moullin JC, Sabater-Hern\u00e1ndez D, Fernandez-Llimos F, et al. A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework. Health Res Policy Sys. 2015;13:16.","journal-title":"Health Res Policy Sys."},{"key":"19792_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1748-5908-1-28","volume":"1","author":"MP Eccles","year":"2006","unstructured":"Eccles MP, Hrisos S, Francis J, et al. Do self-reported intentions predict clinicians\u2019 behaviour: a systematic review. Implementation Sci. 2006;1:28.","journal-title":"Implementation Sci."},{"key":"19792_CR15","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.3390\/ijerph191912775","volume":"19","author":"B Ambuehl","year":"2022","unstructured":"Ambuehl B, Inauen J. Contextualized measurement scale adaptation: a 4-step tutorial for health psychology research. Int J Environ Res Public Health. 2022;19:12775.","journal-title":"Int J Environ Res Public Health."},{"key":"19792_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fpubh.2018.00149","volume":"6","author":"GO Boateng","year":"2018","unstructured":"Boateng GO, Neilands TB, Frongillo EA, et al. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health. 2018;6:149.","journal-title":"Front Public Health."},{"key":"19792_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/109442819800100106","volume":"1","author":"TR Hinkin","year":"1998","unstructured":"Hinkin TR. A brief tutorial on the development of measures for use in survey questionnaires. Organizational Res Methods. 1998;1:104\u201321.","journal-title":"Organizational Res Methods."},{"key":"19792_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13012-018-0782-1","volume":"13","author":"JC Moullin","year":"2018","unstructured":"Moullin JC, Ehrhart MG, Aarons GA. development and testing of the measure of innovation-specific implementation intentions (MISII) using rasch measurement theory. Implement Sci. 2018;13:89.","journal-title":"Implement Sci."},{"key":"19792_CR19","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/00187267211070769","volume":"75","author":"B Holtom","year":"2022","unstructured":"Holtom B, Baruch Y, Aguinis H, et al. Survey response rates: trends and a validity assessment framework. Human Relations. 2022;75:1560\u201384.","journal-title":"Human Relations."},{"key":"19792_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/1043659602250614","volume":"14","author":"J Penrod","year":"2003","unstructured":"Penrod J, Preston DB, Cain RE, et al. A discussion of chain referral as a method of sampling hard-to-reach populations. J Transcult Nurs. 2003;14:100\u20137.","journal-title":"J Transcult Nurs."},{"key":"19792_CR21","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, et al. A consensus-based checklist for reporting of survey studies (CROSS). J Gen Intern Med. 2021;36:3179\u201387.","journal-title":"J Gen Intern Med."},{"key":"19792_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28524","volume":"5","author":"CA Minami","year":"2022","unstructured":"Minami CA, Bryan AF, Freedman RA, et al. Assessment of oncologists\u2019 perspectives on omission of sentinel lymph node biopsy in women 70 years and older with early-stage hormone receptor-positive breast cancer. JAMA Netw Open. 2022;5:e2228524.","journal-title":"JAMA Netw Open."},{"key":"19792_CR23","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1245\/s10434-020-08285-0","volume":"27","author":"ME Smith","year":"2020","unstructured":"Smith ME, Vitous CA, Hughes TM, et al. Barriers and facilitators to de-implementation of the choosing wisely\u00ae guidelines for low-value breast cancer surgery. Ann Surg Oncol. 2020;27:2653\u201363.","journal-title":"Ann Surg Oncol."},{"key":"19792_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1245\/s10434-020-08924-6","volume":"28","author":"N Mott","year":"2021","unstructured":"Mott N, Wang T, Miller J, et al. Medical maximizing-minimizing preferences in relation to low-value services for older women with hormone-receptor positive breast cancer\u2014a qualitative study. Ann Surg Oncol. 2021;28:941\u20139.","journal-title":"Ann Surg Oncol."},{"key":"19792_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jss.2022.11.072","volume":"284","author":"NM Mott","year":"2023","unstructured":"Mott NM, Markovitz NH, Wang T, et al. Avoiding overtreatment of women \u2265\u00a070 With early-stage breast cancer: a provider-level deimplementation strategy. J Surg Res. 2023;284:124\u201330.","journal-title":"J Surg Res."},{"key":"19792_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jgo.2021.02.028","volume":"12","author":"CA Minami","year":"2021","unstructured":"Minami CA, Freedman RA, Karamourtopoulos M, et al. Acceptability of a patient decision aid for women aged 70 and older with stage I, estrogen receptor-positive, HER2-negative breast cancer. J Geriatr Oncol. 2021;12:724\u201330.","journal-title":"J Geriatr Oncol."},{"key":"19792_CR27","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jgo.2019.05.004","volume":"10","author":"MA Schonberg","year":"2019","unstructured":"Schonberg MA, Freedman RA, Recht AR, et al. Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer. J Geriatr Oncol. 2019;10:980\u20136.","journal-title":"J Geriatr Oncol."},{"key":"19792_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/jamasurg.2024.2407","volume":"159","author":"N Carleton","year":"2024","unstructured":"Carleton N, Radomski TR, Li D, et al. Electronic health record-based nudge intervention and axillary surgery in older women with breast cancer: a nonrandomized controlled trial. JAMA Surgery. 2024;159:1117\u201325.","journal-title":"JAMA Surgery."},{"key":"19792_CR29","doi-asserted-by":"publisher","first-page":"e2300177","DOI":"10.1200\/CCI.23.00177","volume":"8","author":"N Carleton","year":"2024","unstructured":"Carleton N, Saadawi G, McAuliffe PF, et al. Use of natural language understanding to facilitate surgical de-escalation of axillary staging in patients with breast cancer. JCO Clin Cancer Inform. 2024;8:e2300177.","journal-title":"JCO Clin Cancer Inform."},{"key":"19792_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.1217330","volume":"337","author":"TW Valente","year":"2012","unstructured":"Valente TW. Network Interventions. Science. 2012;337:49\u201353.","journal-title":"Science."},{"key":"19792_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282050","volume":"18","author":"AG Saatchi","year":"2023","unstructured":"Saatchi AG, Pallotti F, Sullivan P. Network approaches and interventions in healthcare settings: a systematic scoping review. PLoS One. 2023;18:e0282050.","journal-title":"PLoS One."},{"key":"19792_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002890","volume":"16","author":"RF Hunter","year":"2019","unstructured":"Hunter RF, de la Haye K, Murray JM, et al. Social network interventions for health behaviours and outcomes: a systematic review and meta-analysis. PLoS Med. 2019;16:e1002890.","journal-title":"PLoS Med."},{"key":"19792_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.sopen.2025.05.004","volume":"26","author":"KU Park","year":"2025","unstructured":"Park KU, Brindle M, Neuman H, et al. Importance of social ties in dissemination of commission on cancer\u2019s synoptic operative report. Surg Open Sci. 2025;26:61\u20133.","journal-title":"Surg Open Sci."},{"key":"19792_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1513","volume":"342","author":"JE Wennberg","year":"2011","unstructured":"Wennberg JE. Time to tackle unwarranted variations in practice. BMJ. 2011;342:d1513.","journal-title":"BMJ."},{"key":"19792_CR35","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/MLR.0b013e3181ef97df","volume":"48","author":"SJ Katz","year":"2010","unstructured":"Katz SJ, Hawley ST, Abrahamse P, et al. Does it matter where you go for breast surgery?: attending surgeon\u2019s influence on variation in receipt of mastectomy for breast cancer. Med Care. 2010;48:892\u20139.","journal-title":"Med Care."},{"key":"19792_CR36","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1245\/s10434-025-18534-9","volume":"33","author":"GN Tortorello","year":"2026","unstructured":"Tortorello GN, Shafique N, De Jesus EM, et al. Sentinel lymph node biopsy in low-risk breast cancer in patients \u2265 70 years: How Wisely are We Choosing? Ann Surg Oncol. 2026;33:1212\u201320.","journal-title":"Ann Surg Oncol."},{"key":"19792_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10549-025-07789-1","volume":"214","author":"MB Thomas","year":"2025","unstructured":"Thomas MB, Ghaffar SA, Kadri H, et al. Multi-level factors drive use of sentinel lymph node biopsy in older women with early-stage breast cancer. Breast Cancer Res Treat. 2025;214:37\u201348.","journal-title":"Breast Cancer Res Treat."},{"key":"19792_CR38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMoa040587","volume":"351","author":"KS Hughes","year":"2004","unstructured":"Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971\u20137.","journal-title":"N Engl J Med."},{"key":"19792_CR39","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","volume":"31","author":"KS Hughes","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women Age 70 Years or older with early breast cancer: long-term Follow-Up of CALGB 9343. J Clin Oncol. 2013;31:2382\u20137.","journal-title":"J Clin Oncol."},{"key":"19792_CR40","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1200\/JCO.2002.11.101","volume":"20","author":"B Fisher","year":"2002","unstructured":"Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141\u20139.","journal-title":"J Clin Oncol."},{"key":"19792_CR41","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","volume":"388","author":"IH Kunkler","year":"2023","unstructured":"Kunkler IH, Williams LJ, Jack WJL, et al. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388:585\u201394.","journal-title":"N Engl J Med."},{"issue":"2","key":"19792_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2024","unstructured":"Shaitelman SF, Anderson BM, Arthur DW, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma In Situ: An ASTRO clinical practice guideline. Pract Radiat Oncol. 2024;14(2):112\u201332. https:\/\/doi.org\/10.1016\/j.prro.2023.11.001.","journal-title":"Pract Radiat Oncol."},{"key":"19792_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.110069","volume":"191","author":"VM Wintraecken","year":"2024","unstructured":"Wintraecken VM, Boersma LJ, van Roozendaal LM, et al. Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013\u201308 trial. Radiother Oncol. 2024;191:110069. https:\/\/doi.org\/10.1016\/j.radonc.2023.110069.","journal-title":"Radiother Oncol."},{"key":"19792_CR44","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1904819","volume":"380","author":"JA Sparano","year":"2019","unstructured":"Sparano JA, Gray RJ, Ravdin PM, et al. Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer. N Engl J Med. 2019;380:2395\u2013405.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19792-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19792-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:01:38Z","timestamp":1786248098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19792-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19792"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19792-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EAM reports compensated service on scientific advisory boards for Astra Zeneca, BioNTech, Merck and Moderna; uncompensated service on steering committees for Bristol Myers Squibb and Roche\/Genentech; speakers honoraria and travel support from Merck Sharp & Dohme; institutional research support from Roche\/Genentech (via SU2C grant) and Gilead; research funding from Susan Komen for the Cure for which she serves as a scientific advisor; and uncompensated participation as a member of the American Society of Clinical Oncology Board of Directors. TAK reports speaker honoraria for Exact Sciences, compensated service on the FES Steering Committee for GE Healthcare, compensated service for a Prosigna advisory board role for Veracyte, compensated service on the advisory board for Ataraxia AI, and compensated service as faculty for PrecisCa cancer information service.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Presented in part as a poster at the 2025 San Antonio Breast Cancer Symposium.","order":2,"name":"Ethics","label":"Prior presentation","group":{"name":"EthicsHeading","label":"Ethics"}}]}}